Colossal Biosciences Valuation, Funding & Investors

Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company owns the TERRYL brand, which focuses on bio-based polyamide fibers for textiles, and ECOPENT, which serves the engineering materials market.

Bluepha is a Singapore-headquartered biotechnology company that engineers bio-based materials using microbial fermentation and data analytics. The firm develops alternatives to petroleum plastics for packaging, textiles, and consumer goods, targeting industries like personal care and agriculture. Founded in 2020, Bluepha collaborates with global chemical producers to scale production of its polyhydroxyalkanoate polymers.

Spiber is a Tokyo-headquartered biotechnology firm founded in September 2007 producing Brewed Protein synthetic fibers via microbial fermentation of plant-based feedstocks. The proteins replace silk, wool, and petroleum plastics in apparel like The North Face Moon Parka and automotive interiors for Nissan. Spiber operates a mass production plant in Rayong, Thailand since 2021 and builds a second facility with ADM in Iowa set for 2023 operations. Partnerships with Itochu and Teijin enable commercialization of Brewed Protein polymers targeting 10,000 tons annual output by mid-decade.

Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.

Sangon Biotech is a Shanghai-based biotechnology firm specializing in nucleic acid synthesis and molecular biology products. Founded in 2003 as a Sino-foreign joint venture, it manufactures DNA/RNA oligonucleotides, gene synthesis services, peptides, enzymes, reagents, lab consumables, and benchtop instruments. The company operates a production base in Songjiang Industrial Park, serving research institutions and pharmaceutical companies worldwide.

SABIC Agri-Nutrient Co is engaged in the production, conversion, manufacturing, and trade of agri-nutrients and chemical products. Also, the Company is engaged in the marketing of agri-nutrient products of all types inside and outside KSA. The Group is organised into two segments; The Agri-Nutrients and The Petrochemicals. The majority of revenue is derived from the Agri-Nutrients segment.

Industries Qatar QSC, along with its subsidiaries, operates in the following reportable segments: Petrochemicals, Fertilisers, and Steel. Maximum revenue is generated from the Fertilisers segment, which produces and sells urea, ammonia, and other by-products. The Petrochemicals segment produces and sells ethylene, polyethylene, MTBE, methanol, and other petrochemical products; and the Steel segment produces and sells steel pellets, bars, billets, and others.

Qinghai Salt Lake Industry Co Ltd operates in the dry inland Qarhan Salt Lake in Qinghai province. It is engaged in salt lake resource extraction and potash production. The company is engaged in the manufacture of chemical raw materials and chemical products. The company's main products include potassium chloride and lithium carbonate.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.

Fertiglobe PLC is engaged in the production of urea, ammonia, and other gas-based fertilizers for export and distribution. The company's portfolio of products comprises ammonia, urea for agricultural and industrial customers, and DEF, which is also known as AdBlue in Europe and marketed as AdGreen by FERTIL, for industrial customers. The company operates in Europe, North America, South America, Africa, Middle East, Asia and Oceania. Majority of revenue is from Europe.

PI Industries Ltd manufactures, distributes, and sells agrochemicals, specialty fertilizers, and seeds to the agriculture industry. The firm's agrochemicals portfolio includes insecticides, fungicides, and plant health products. The company competes on price with the manufacture and sale of generic products. PI Industries reports sales across two geographical segments: within India and outside India. The outside India division represents its business division predominantly in Japan, Germany, and China. In India, the firm sells its products through a large network of distributors and retail outlets. The company has one reportable business segment which is Agro Chemicals.

K+S AG produces two products: fertilizer and salt. The company engaged in business with potash and magnesium products from plants in Germany and Canadian sites in Bethune, as well as the European salt activities. It also includes the waste disposal and recycling business in Germany. extraction and processing of raw materials.

Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.

Inari is a West Lafayette-headquartered biotechnology company developing seed traits through multiplex gene editing and predictive design via its SEEDesign platform. The firm targets corn, soybean, and wheat improvements for yield, drought tolerance, and nitrogen use efficiency. Founded in 2016, Inari operates greenhouses and field trial sites across the US Midwest and Brazil. It collaborates with Corteva and Bayer on commercialization pipelines for hybrid varieties suited to diverse climates.

Biobest is a Belgium-headquartered supplier of biological crop protection and pollination systems. Based in Westerlo, it offers bumblebees for pollination, beneficial insects and mites like Phytoseiulus persimilis, nematodes, biopesticides, sticky traps, and pheromone lures to growers internationally.

EcoCeres is a Hong Kong-based advanced biorefinery company converting waste-based biomass into lower-carbon transport fuels and renewable chemical products. Its principal outputs include sustainable aviation fuel and hydrotreated vegetable oil made from used oils, agricultural residues and other waste feedstocks. EcoCeres supplies airlines, fuel distributors and transport-sector customers seeking certified substitutes for fossil jet fuel and diesel. Revenue is generated through industrial production and long-term sales of renewable fuels, supported by proprietary pretreatment and refining technology. The Hong Kong-headquartered company has developed commercial production in Asia and entered partnerships aimed at expanding sustainable aviation fuel adoption. HKIC’s capital and ecosystem support are intended to accelerate technology development, international market access and Hong Kong’s role in sustainable aviation.

Merck KGaA operates in three main segments: life science, electronics, and healthcare. The life science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck family publicly sold part of the company, resulting in the current 30% public ownership of the firm.